%) were taking aspirin, aspirin
use was associated with reduced stroke severity and
improved functional outcome.115
Several studies offer strong evidence supporting the efÔ¨Åcacy of antiplatelet therapy for secondary prevention
among patients with symptomatic carotid artery disease116-122 and a meta-regression analysis of 11 trials
demonstrated an approximate 15% reduction in stroke
risk associated with aspirin use.123